Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6290
-0.0294 (-4.47%)
At close: Oct 16, 2026, 4:00 PM EDT
0.6557
+0.0267 (4.24%)
After-hours: Oct 16, 2026, 7:56 PM EDT
Standard BioTools Employees
As of December 31, 2025, Standard BioTools had 389 total employees, including 385 full-time and 4 part-time employees. The number of employees decreased by 429 or -52.44% compared to the previous year. That makes Standard BioTools the 21,975th largest employer in the world and 2,872nd in the United States.
Employees
389
Change (1Y)
-429
Growth (1Y)
-52.44%
Revenue / Employee
$217,473
Profits / Employee
$218,267
Market Cap
246.93M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 389 | -429 | -52.44% | 385 | 4 |
| Dec 31, 2024 | 818 | 279 | 51.76% | 814 | 4 |
| Dec 31, 2023 | 539 | 16 | 3.06% | 534 | 5 |
| Dec 31, 2022 | 523 | -92 | -14.96% | 523 | 0 |
| Dec 31, 2021 | 615 | -12 | -1.91% | 615 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| Treace Medical Concepts | 450 |
| Electromed | 197 |
| ClearPoint Neuro | 172 |
| Perspective Therapeutics | 166 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
LAB News
- 13 days ago - Standard BioTools to sell Microfluidics business to Archimed, terms undisclosed - TheFly
- 13 days ago - Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED - GlobeNewsWire
- 18 days ago - Standard BioTools provides update on sale of mass cytometry business - TheFly
- 18 days ago - Standard BioTools Provides Update on Sale of Mass Cytometry Business - GlobeNewsWire
- 2 months ago - Standard BioTools Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Standard BioTools Earnings release: Q2 2026 - Filings
- 2 months ago - Standard BioTools Quarterly report: Q2 2026 - Filings
- 2 months ago - Standard BioTools to sell Mass Cytometry business to Multiplex Bio for $10M - TheFly